PLoS ONE (Jan 2018)

Low-level laser treatment applied at auriculotherapy points to reduce postoperative pain in third molar surgery: A randomized, controlled, single-blinded study.

  • Hélio Sampaio-Filho,
  • Sandra Kalil Bussadori,
  • Marcela Leticia Leal Gonçalves,
  • Daniela de Fátima Teixeira da Silva,
  • Maria Cristina Borsatto,
  • Isabel Peixoto Tortamano,
  • Priscila Larcher Longo,
  • Christiane Pavani,
  • Kristianne Porta Santos Fernandes,
  • Raquel Agnelli Mesquita-Ferrari,
  • Anna Carolina Ratto Tempestini Horliana

DOI
https://doi.org/10.1371/journal.pone.0197989
Journal volume & issue
Vol. 13, no. 6
p. e0197989

Abstract

Read online

OBJECTIVE:Evaluate the effectiveness of LLL (Low level laser therapy) in auriculotherapy points for pain reduction following lower third molar extractions. STUDY DESIGN:Randomized, controlled, single-blinded study. METHODS:Eighty-four bilateral, symmetrical third molar surgeries were performed in 42 healthy patients using a split-mouth design. In the immediate postoperative period, each side was randomly treated in a single-blind method with an LLL at the auriculotherapy points or simulation of its use (contralateral side) over a 21-day interval. This protocol was repeated 24 and 48 hours after surgery. All patients used the same analgesic (paracetamol) but only in case of pain. The primary variable was postoperative pain according to the visual analogue scale, and the secondary variables were mouth opening, edema, local temperature, dysphagia, and the presence of infection (systemic temperature, lymphadenopathy). These variables were evaluated at baseline and at 24 hours, 48 hours and seven days after surgery. Adverse effects were recorded and reported. RESULTS:There was no difference between the groups in relation to any of the evaluated parameters (p>0.05). CONCLUSION:For this experimental model, application of a low-intensity laser at auriculotherapy points did not prevent postoperative pain following lower third molar surgery. TRIAL REGISTRATION:This trial is registered at ClinicalTrials.gov; the registration number is NCT02657174 and the Unique Protocol ID number is 1.100.869. (https://register.clinicaltrials.gov/prs/app/template/EditRecord.vm?epmode=View&listmode=Edit&uid=U0002BEY&ts=11&sid=S0006026&cx=6g4wff).